September 22, 2020
EMBLEM Technology Transfer GmbH and PreOmics® enter into Licensing Agreement for proteomics sample preparation technology
EMBL Enterprise Management Technology Transfer GmbH (EMBLEM), the technology transfer arm of the European Molecular Biology Laboratory (EMBL), Europe’s flagship laboratory in the life sciences, and PreOmics®, a developer of innovative technologies for mass spectrometry-based sample preparation, announced today that they have entered into an exclusive licensing agreement for EMBL’s proprietary SP3 technology, a high-throughput technology for proteomic sample preparation.